Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-05-19
DOI
10.1093/ibd/izaa108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- P066 The relationship between serum adalimumab and corresponding anti-adalimumab antibody levels
- (2019) Chun Kelly et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- P058 Serum infliximab and corresponding anti-infliximab antibody
- (2019) Chun Kelly et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel Disease
- (2019) Laura E Bauman et al. INFLAMMATORY BOWEL DISEASES
- The REDCap consortium: Building an international community of software platform partners
- (2019) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Management of Anti-drug Antibodies (ADA) to Biologic Medications in Children with Inflammatory Bowel Disease
- (2019) Reuven Zev Cohen et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease
- (2018) Konstantinos Papamichael et al. DIGESTIVE DISEASES AND SCIENCES
- Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohnʼs Disease
- (2017) William A. Faubion et al. INFLAMMATORY BOWEL DISEASES
- Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
- (2017) Subra Kugathasan et al. LANCET
- Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn’s Disease Is Determined by Their Concentration
- (2016) Helena Edlund et al. AAPS Journal
- Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab
- (2016) B. Ungar et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies
- (2016) Casper Steenholdt et al. INFLAMMATORY BOWEL DISEASES
- Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn’s Disease
- (2015) Victoria Grossi et al. Clinical Gastroenterology and Hepatology
- Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
- (2015) Henit Yanai et al. Clinical Gastroenterology and Hepatology
- Optimal Doses of Methotrexate Combined with Anti-TNF Therapy to Maintain Clinical Remission in Inflammatory Bowel Disease
- (2015) R. J. Colman et al. Journal of Crohns & Colitis
- Influence of Combination Therapy with Immune Modulators on Anti-TNF Trough Levels and Antibodies in Patients with IBD
- (2014) Tamara van Schaik et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease
- (2013) Stephane Paul et al. INFLAMMATORY BOWEL DISEASES
- Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease
- (2012) Shomron Ben–Horin et al. Clinical Gastroenterology and Hepatology
- Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children
- (2012) Jeffrey S. Hyams et al. GASTROENTEROLOGY
- Improved Outcomes With Quality Improvement Interventions in Pediatric Inflammatory Bowel Disease
- (2012) Charles M. Samson et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Association of Crohn’s Disease, Thiopurines, and Primary Epstein-Barr Virus Infection with Hemophagocytic Lymphohistiocytosis
- (2011) Vincent F. Biank et al. JOURNAL OF PEDIATRICS
- A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
- (2010) David S. Kotlyar et al. Clinical Gastroenterology and Hepatology
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
- (2008) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started